Covid-19 mrna vaccine tolerance and immunogenicity in hematopoietic stem cell transplantation recipients aged 5-11 years old-non-randomized clinical trial

HIGHLIGHTS

• who: Agnieszka Matkowska-Kocjan and collaborators from the Department and Clinic of Pediatric Infectious Diseases, Wroclaw Medical University, Wrocu0142aw, Poland have published the research work: COVID-19 mRNA Vaccine Tolerance and Immunogenicity in Hematopoietic Stem Cell Transplantation Recipients Aged 5-11 Years Old-Non-Randomized Clinical Trial, in the Journal: Vaccines 2023, 195 of 18/Dec/2021
• what: The aim of this prospective study was to evaluate the safety and efficacy of the mRNA BNT162b2 (Pfizer/Biontech) vaccine in allogeneic hematopoietic stem cell (alloHSCT) Material and methods: Two cohorts of 34 children after allo-HSCT . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.